Although increment of H19 may partly contribute to miR675 medicated promotion of liver cancer cell growth, our findings in this study provide novel evidence for an active role of H19 in miR675-mediated promotion of liver cancer cell growth. The gene discussed is H19; the disease is liver cancer.